Velcade®
Company
Millennium Pharmaceuticals, Inc.
Use
Treatment for multiple myeloma that works by specifically inhibiting an enzyme complex known as the proteosome.
Features
First proteosome inhibitor to be approved by the FDA
NIH Contribution
Creation of a freeze-dried powder formulation of boronic acid compounds resulting in longer stable shelf life
Approval Type
FDA
HHS Institute/Agency
NCI
Inventor(s)
S. Gupta
Year
2003
Tech Cat
Therapeutic
